Provided by Tiger Trade Technology Pte. Ltd.

Ovid Therapeutics Inc.

2.49
+0.08883.70%
Volume:824.30K
Turnover:2.01M
Market Cap:375.81M
PE:-10.82
High:2.51
Open:2.33
Low:2.31
Close:2.40
52wk High:2.72
52wk Low:0.2425
Shares:151.00M
Float Shares:120.00M
Volume Ratio:0.29
T/O Rate:0.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2300
EPS(LYR):-0.2325
ROE:-17.51%
ROA:-21.82%
PB:2.88
PE(LYR):-10.71

Loading ...

Feb 13, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Sep 11, 2024

Major Issues Report

Form 8-K - Current report
Aug 13, 2024

Major Issues Report

Form 8-K - Current report
Aug 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2024

Major Issues Report

Form 8-K - Current report
Jul 01, 2024

Major Issues Report

Form 8-K - Current report
Jun 28, 2024

Major Issues Report

Form 8-K - Current report
Jun 17, 2024

Major Issues Report

Form 8-K - Current report
Jun 07, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Major Issues Report

Form 8-K - Current report
Mar 08, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 08, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]